First FDA-Approved System Provides Real-Time Data for Cardiogenic Shock
News and Press Releases
Etiometry was recently featured in a Medscape interview with insights from our co-founder and CTO, Dimitar Baronov, alongside clinicians Walter Schiffer, MD, Cardiologist at Washington University School of Medicine and Srihari Naidu, MD, President of SCAI.
The article highlights the importance of early identification in cardiogenic shock and how integrating continuous physiologic data with EHR, lab, and device inputs can support more timely clinical decisions.
Dr. Schiffer highlights that the tool helps the clinical team at BJH to prioritize which patients need the most attention, and potentially start treatment earlier, improving the odds of survival.
Read the full article to learn more: https://www.medscape.com/viewarticle/first-fda-approved-system-provides-real-time-data-2026a1000cng?src=rss
Related
Etiometry has been named one of the “Top Most Influential Companies to Watch 2026” by BizTech Outlook.
With recent FDA clearance for the first and only Hospital-Specific Cardiogenic Shock Classification and Tracking tool, we’re expanding how care teams can identify risk earlier and intervene with greater precision. The article highlights how critical care is evolving, using continuous data to help clinicians spot changes sooner and make more informed decisions at the bedside. […]
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking
BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification […]